Eurofins Scientific SEERFSF +2.60%81 OCF Yield % is 12.29 as of Jun. 25, 2026, which is 55% above its 10-year median of 7.95. GuruFocus rates ERFSF with a GF Score™ of 81/100 and a GF Value™ of $76.00 (Fairly Valued). The stock has 6 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 91.63% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Eurofins Scientific SE OCF Yield % Related Terms
Eurofins Scientific SE OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Eurofins Scientific SE's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (ERFSF) has a OCF Yield % of 12.29 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Eurofins Scientific SE and its competitors. This is 55% above median its historical median of 7.95. Over the past decade, Eurofins Scientific SE's OCF Yield % has ranged from 3.98 to 14.41. According to the industry distribution chart, Eurofins Scientific SE ranks #18 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 8.4%.
Is Eurofins Scientific SE's OCF Yield % too high?
Eurofins Scientific SE's current OCF Yield % of 12.29 is 55% above median its 10-year median of 7.95. Over the past 10 years, this metric has ranged from a low of 3.98 to a high of 14.41. The Medical Diagnostics & Research industry median OCF Yield % is 1.09. Eurofins Scientific SE's value of 12.29 is 1027.5% above this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #18 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #18 out of 215 companies for OCF Yield %. This places Eurofins Scientific SE in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.09. Eurofins Scientific SE's value of 12.29 is 1027.5% above this benchmark. Historically, Eurofins Scientific SE's own OCF Yield % has ranged from 3.98 to 14.41 over the past decade. While the company's 10-year median is 7.95 vs. the industry median of 1.09, Eurofins Scientific SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.09, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current OCF Yield % of 12.29 is 1027.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current OCF Yield % is 12.29, which is 55% above median its own 10-year median of 7.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $76.00, compared to a current price of $76.03 — trading 0% above its estimated fair value. The current OCF Yield % is 12.29, which is 55% above median its 10-year median of 7.95 and 1027.5% above the Medical Diagnostics & Research industry median of 1.09. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current OCF Yield % is 12.29 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $76.03 is trading 0% above its estimated GF Value™ of $76.00.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
OCF Yield %: 12.29 (55% above median its 10-year median of 7.95)
GF Value™: $76.00 vs. price of $76.03 (0% above fair value)
Industry Position: 1027.5% above the Medical Diagnostics & Research median (#18 of 215)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score
Get the complete analysis for ERFSF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
